Classification
- Anatomical main groupJAnti-infectives for systemic use
- Therapeutic subgroupJ07
- Pharmacological subgroupJ07A
- Chemical subgroupJ07AHMeningococcal vaccines
- Chemical substanceJ07AH09Meningococcus b, multicomponent vaccine
Where it is registered
Each register with its number of medicines and a few of them.
All medicines with Meningococcal group b vaccine
Every register, a page at a time. Strengths and packs are on each medicine’s page.
14 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Bexsero | United States | 0.5ML | Injection | Marketed | GlaxoSmithKline Biologicals |
| Trumenba | United States | 0.5ML | Injection | Marketed | Wyeth Pharmaceuticals LLC |
| PenmenvyCombination | United States | 25UG/0.5ML | Injection | Marketed | GlaxoSmithKline Biologicals |
| PenbrayaCombination | United States | 5UG | Injection | Marketed | Pfizer Ireland Pharmaceuticals Unlimited Company |
| MenveoCombination | United States | 0.5ML | Injection | Marketed | GlaxoSmithKline Biologicals |
| MenveoCombination | United States | 0.5ML | Injection | Marketed | GlaxoSmithKline Biologicals |
| MenactraCombination | United States | 48UG/.5ML | For Injection | Marketed | Sanofi Vaccines US Inc. |
| Menquadfi | United States | 0.5ML | Injection | Marketed | Sanofi Vaccines US Inc. |
| MenhibrixCombination | United States | 0.5ML | Injection | Withdrawn | GlaxoSmithKline Biologicals |
| MenomuneCombination | United States | 50UG/.5ML | For Injection | Withdrawn | Sanofi Vaccines US Inc. |
| Menomune-A | United States | 0.5ML | For Injection | Withdrawn | Sanofi Vaccines US Inc. |
| Menomune-C | United States | 0.5ML | For Injection | Withdrawn | Sanofi Vaccines US Inc. |
| Menomune-A/CCombination | United States | 50UG/.5ML | For Injection | Withdrawn | Sanofi Vaccines US Inc. |
| Menomune-A/CCombination | United States | 50UG/.5ML | For Injection | Withdrawn | Sanofi Vaccines US Inc. |